What one share of Shoulder Innovations holds
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.
Shoulder Innovations’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.18 |
|---|---|
| Profit | −$1.86 |
| Capex (buildings and equipment) | $0.53 |
| Free cash flow | −$2.49 |
| Cash and investments | $1.17 |
| Debt | $0.71 |
| Book value | $5.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2025 | $5.46 | −$4.65 | $0.85 | −$4.15 | — | $6.82 |
Common questions about Shoulder Innovations
How much does one share of Shoulder Innovations earn?
Over the last 12 months, Shoulder Innovations lost $1.86 for each share on $3.18 of sales.
Does Shoulder Innovations pay a dividend?
Shoulder Innovations didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Shoulder Innovations’s book value per share?
Shoulder Innovations’s book value is $5.97 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Shoulder Innovations have?
Each share of Shoulder Innovations has $1.17 of cash and investments and $0.71 of debt, as of June 30, 2026.
What is Shoulder Innovations’s free cash flow per share?
−$2.49 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.